Together Against Cancer: the United Kingdom

ECO Time to accelerate_for-our-workforce.png

Cancer Workforce Fund Launch

Cancer Workforce Fund Launch - interview visual (3).png

Watch Andreas Charalambous, ECO Past-president and founder of the European Cancer Community Foundation and CEO Mike Morrissey live on GB News, presenting the launch of the Cancer Workforce Fund on 4 April at the Mansion House in London. They addressed the pressing issues brought by the Cancer Workforce Crisis in the UK and Europe.

London highlights 2 (1).png

The shortage of doctors, nurses, pharmacists, pathologists and other professionals involved in cancer care is placing immense strains on healthcare systems and negatively affecting patient care. While governmental and institutional policies try to address the workforce challenge, financial backing is essential to bolster efforts to take practical action.

On 4 April 2024, the European Cancer Community Foundation launched the Cancer Workforce Fund to support on-the ground projects in the healthcare and community setting, providing meaningful solutions to the current workforce crisis. By supporting projects to explore new processes, apply new innovations and improve working conditions of those on the frontlines of cancer care, we enable them to remain focused on their mission: providing the best possible care for their patients.

Cancer Workforce Fund Launch - interview visual (5).png

The video above shows how the team of Mirjam Crul, Co-Chair of the ECO Workforce Network, is working on a new method to make it easier for patients to receive chemotherapy at home. This is one of the many possibilities for this fund.

The Lord Mayor of The City of London, Michael Mainelli, hosted the launch at the Mansion House in London on 4 April 2024. The speakers included:

  • Andreas Charalambous, Founder and Chair, European Cancer Community Foundation, Immediate Past-President, European Cancer Organisation and Founder, and Professor at the Cyprus University of Technology;
  • Kathy Oliver, Patient Advisory Committee Co-Chair, European Cancer Organisation (ECO) and Co-Director, International Brain Tumour Alliance (IBTA);
  • Ajay Aggarwal, Consultant Clinical Oncologist, Guy’s & St Thomas’ NHS Trust, Professor Cancer Services and Systems Research, London School of Hygiene and Tropical Medicine, and Board Member of the European Cancer Organisation;
  • Mark Lawler, Associate Pro-Vice-Chancellor, Professor of Digital Health, and Chair in Translational Cancer Genomics, Queen's University Belfast (QUB) and Chair of the International Cancer Benchmarking Partnership;
  • Nicolò Matteo Luca Battisti, Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust, Co-Chair and President, International Society of Geriatric Oncology (SIOG) and Co-Chair of the Inequalities Network, European Cancer Organisation;
  • Ann Slee, Former Associate Chief Clinical Information Officer (medicines) NHS England, Senior Advisor to Digital Health and Care Wales;
  • Candice Blackwood, Partner Co-Head Life Sciences & Healthcare, CMS Cameron McKenna Nabarro Olswang;
  • Ed O’Brien, Senior Director EMEA Healthcare, BNP Paribas Real Estate.

If you wish to donate to the fund, please access the European Cancer Community Foundation website and indicate ‘WorkforceFund’ in the description of your donation.

Find out more about the Time to Accelerate: for Our Workforce campaign here.

jpg Cancer Workforce Fund wide speakers

Previous activities in London

The Value of Cancer Plans: ECO provides evidence to UK House of Commons Inquiry

On 9 January 2024, the European Cancer Organisation (ECO) provided evidence to the UK Parliament’s House of Commons Health Select Committee and its inquiry into ‘Future Cancer’.

      microsoftteams image 43

The Inquiry is investigating "... the innovations with the greatest potential to transform cancer diagnosis and treatment for patients in the short, medium and long term, and it will examine how innovations in diagnosing and treating cancer can best be transitioned into frontline clinical settings. It will also explore international examples of best practice.”

Both ECO and the American Society of Clinical Oncology were invited to give oral evidence at a hearing of the Committee. You can find more information on our Policy page

After the hearing, ECO met with Paul Bristow MP who is a member of National & European Parliamentarians for Cancer Action.

Mark Lawler Paul Bristow MP UK 

View More